It has been hypothesized that the trigeminal system may control vasomotor changes and pain in vascular headaches. In this study, headache was induced by an intravenous injection of histamine in 37 patients with trigeminal rhizotomy and in 12 controls. The vasomotor response to histamine was studied with facial telethermography. The headache in patients with trigeminal lesions differed, in a prevalence of unilateral localization contralaterally to the operated side (21 patients), from that in controls. No relationship was found between the hypoesthesia caused by the operation and the prevalence of unilateral headache. A statistically significant correlation (p < 0.001) was found between unilateral absence of headache and decreased vasomotor response on the operated side. These reactions occurred more in patients who underwent thermocoagulation than in patients who underwent retro-gasserian rhizotomy. Thus the gasserian ganglion seems to control the cranio-facial vasomotor response and the headache through a vascular pathway, acting on cerebral arteries, which differs from the sensory pathway.
RayBSWolffHG.Experimental studies on headache. Arch Surgery1940;41:813–56.
2.
PenfieldWMcNaughtonF.Dural headaches and the innervation of the dura mater. Am Neurol Ass1938;64:106–9.
3.
SteigerHJTewJMKellerJT.The sensory representation of the dura mater in the trigeminal ganglion of the cat. Neurosci Lett1982;31:231–6.
4.
WolffHG.Headache and other head pain.2nd edn.New York:Oxford University Press,1963.
5.
WatsonCPMorleyTPRichardsonJCTaskerRR.The surgical treatment of chronic cluster headache. Headache1983;23:289–95.
6.
MoskowitzMAReinhardJFRomeroJMelamedEPettiboneDJ.Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine?Lancet1979;ii:883–5.
7.
Del FiaccoMCuelloAC.Substance P- and enkephalin-containing neurones in the rat trigeminal system. Neuroscience1980;5:803–5.
8.
MassonC.SubstanceP.Nouv Presse Med1981;10:1721–8.
9.
JesselTM.The role of substance P in sensory transmission and pain perception. In:MartinJB.ReichlinSBickKL edsNeurosecretion and brain pep-tides.New York:Raven Press.1981:189–98.
10.
PertA.Mechanisms of opiate analgesia and the role of endorphins in pain suppression. Adv Neurol1982;33:107–21.
11.
Chan PalayV.Innervation of cerebral blood vessels by norepinephrine, indoleamine. substance P and neurotensin fibres and the leptomeningeal indoleamine axons: their roles in vasomotor activity and local alterations of brain blood composition. In:OwmanChEdvinssonL edsNeurogenic control of brain circulation.New York:Pergamon Press.1977:39–53.
12.
EklundB.JogestrandT.PernowB.Effect of substance P on resistance and capacitance vessels in human forearm. In:von EulerUSPernowBedsSubstanceP.New York:Raven Press,1977:275–86.
13.
OwmanCh.EdvinssonL.Histochemical and pharmacological approach to the investigation of neurotransmitters. with particular regard to the cerebrovascular bed. In:OwmanChEdvinssonL edsNeurogenic control of brain circulation.New York:Pergamon Press.1977:15–38.
14.
MaybergMR.LangerR.ZervasNT.MoskowitzMA.Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science1981;213:228–30.
15.
Liu-ChenL-Y.MaybergMR.MoskowitzMA.Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats.Brain Res.1983;268:162–6.
16.
Liu-ChenL-YHanDH.MoskowitzMA.Pia arachnoid contains substance P originating from trigeminal neurons. Neuroscience1983;9:803–8.
17.
MoskowitzMABrodyMLiu-ChenL-Y.In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neuroscience1983;9:809–14.
18.
CoutureRGaudreauPSt-PierreSRegoliD.The dog carotid artery: a sensitive bioassay for studying vasodilator effects of substance P and kinins. Can J Physiol Pharmac1980;58:1234–44.
19.
OlesenJ.LarsenBLauritzenM.Focal hyperemia followed by spreading depression oligemia and impaired activation of rCBF in classic migraine.Ann Neurol19819:344–52.
20.
PickeringGW.HessW.Observations on the mechanism of headache produced by histamine. Clin Sci1933;1:77–101.
21.
SchumacherGARayBS.WolffHG.Experimental studies on headache. Arch Neurol Psychiat1940;44:701–17.
22.
Dalsgaard-NielsenT.Migraine diagnostic with special reference to pharmacological tests. Int Arch Allergy1955;17:312–22.
23.
AgnoliARuggieriSDenaroAMartucciN.The histamine test in the diagnosis of vascular headache revisited. In:Sicuteri Fed Headache: new vistas.Florence (Italy):Biomedical Press.1977:163–71.
24.
OhnhausEE.AdlerR.Methodological problems in the measurement of pain: a comparison between the verbal rating scale and the visual analogue scale.Pain1975:1:379–83.
25.
ScottJHuskissonEC.Graphic representation of pain. Pain1976;2:175–84.
26.
LoveTJ.Thermography as an indicator of blood perfusion.Ann NY Acad Sci1980:335:429–37.
27.
DrummondPD.LanceJW.Extracranial vascular changes and the source of pain in migraine headache. Ann Neurol1983;13:32–7.
28.
LanceJW.LambertGAGoadsbyPJDuckworthJW.Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache1983;23:258–65.
29.
DrummondPD.GonskiA.LanceJW.Facial flushing after thermocoagulation of the gasserian ganglion. J Neurol Neurosurg Psychiatry1983;46:611–16.
30.
SicuteriF.Natural opioids in migraine. Adv Neurol1982;33:65–74.
31.
StirlingMeye' JHardenbergJ.Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache1983;23:266–77.
32.
PeroutkaSJ.The pharmacology of calcium channel antagonists: a novel class of anti-migraine agents?Headache1983;23:278–83.
33.
O'BrienMD.Cerebral blood changes in migraine. Headache1971;10:139–43.
34.
LauritzenMOlsenTS.LassenNAPaulsonOB.Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol1983;13:633–41.
